IDiyas

For the Inventor, By the Inventor

Gales Ferry, CT, United States of America

Brian S Bronk

USPTO Granted Patents = 18

Average Co-Inventor Count = 4.5

ph-index = 8

Forward Citations = 216(Granted Patents)


Company Filing History:

goldMedal18 out of 4,455 
 
Pfizer Corporation
 patents

Years Active: 2000-2009

Loading Chart...
18 patents (USPTO):Explore Patents
1. 7482368 - Triamide-substituted heterobicyclic compounds (2009-01-27),
2. 7348355 - Triamide-substituted heterobicyclic compounds (2008-03-25),
3. 6979692 - Triamide-substituted heterobicyclic compounds (2005-12-27),
4. 6949572 - Triamide-substituted heterobicyclic compounds (2005-09-27),
5. 6936592 - 4″-substituted-9-deoxo-9a-aza-9a-homoerythromycin A derivatives (2005-08-30),
6. 6846818 - Selective inhibitors of cyclooxygenase-2 (2005-01-25),
7. 6841671 - Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors (2005-01-11),
8. 6777393 - 4″-substituted-9-deoxo-9a-aza-9a homoerythromycin a derivative (2004-08-17),
9. 6720351 - Triamide-substituted heterobicyclic compounds (2004-04-13),
10. 6649636 - Heteroaryl phenyl pyrazole compounds as anti-inflammatory/analgesic agents (2003-11-18),
11. 6576749 - C-4″-substituted macrolide derivatives (2003-06-10),
12. 6479516 - 4-arylpiperidine derivatives for the treatment of pruritus (2002-11-12),
13. 6441000 - Compounds useful in therapy (2002-08-27),
14. 6420536 - 4″-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives (2002-07-16),
15. 6407074 - C-4″-substituted macrolide derivatives (2002-06-18),

Title: Innovations of Brian S Bronk

Introduction

Brian S Bronk is a notable inventor based in Gales Ferry, Connecticut. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating obesity and lipid disorders. With a total of 18 patents to his name, Bronk's work has had a considerable impact on medical science.

Latest Patents

Among his latest patents, Bronk has developed triamide-substituted heterobicyclic compounds. These inventions relate to triamide MTP/ApoB inhibitors, which are useful for the treatment of obesity and lipid disorders. The compounds are defined by a specific formula, wherein R-R are as specified in the patent documentation. Additionally, these patents include pharmaceutical compositions and processes for preparing the compounds.

Career Highlights

Brian S Bronk is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to focus on innovative solutions in the healthcare sector. His extensive experience and expertise have positioned him as a key player in the development of new therapeutic agents.

Collaborations

Throughout his career, Bronk has collaborated with several talented individuals, including Hengmiao Cheng and Michael Anthony Letavic. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

In summary, Brian S Bronk is a distinguished inventor whose work in pharmaceutical innovations has led to significant advancements in treating obesity and lipid disorders. His contributions continue to shape the future of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…